Medivation Prostate Therapeutics, Inc.
Records under this name other than the patents Medivation Prostate Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 4 of 4 · Back to Medivation Prostate Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,710,086 | Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,023,869 | Substituted Phenylcarbamoyl Alkylamino Arene Compounds and N,n'-Bis-Arylurea Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,126,962 | Substituted phenylcarbamoyl alkylamino arene compounds and N,N′-BIS-arylurea compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,447,128 | Formulations of Enzalutamide Held by another company In force · High confidence | In force | High confidence |